• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Higher In-Hospital Mortality among Asian Americans Undergoing Transjugular Intrahepatic Portosystemic Shunt Procedure.接受经颈静脉肝内门体分流术的亚裔美国人住院死亡率较高。
Visc Med. 2024 Aug;40(4):169-175. doi: 10.1159/000538356. Epub 2024 Apr 9.
2
Advanced chronic renal disease is an independent risk factor for inpatient mortality following transjugular intrahepatic portosystemic shunt procedure.晚期慢性肾脏疾病是经颈静脉肝内门体分流术治疗后住院患者死亡的独立危险因素。
Eur J Gastroenterol Hepatol. 2024 Mar 1;36(3):332-337. doi: 10.1097/MEG.0000000000002703. Epub 2023 Dec 27.
3
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术治疗肝硬化的效果比较。
Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2.
4
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.肌肉减少症是经颈静脉肝内门体分流术肝性脑病和死亡率的一个风险因素:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12.
5
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding.确定肝硬化合并静脉曲张出血患者经颈静脉肝内门体分流术后门静脉压力梯度的最佳测量时机和血流动力学目标。
J Hepatol. 2025 Feb;82(2):245-257. doi: 10.1016/j.jhep.2024.08.007. Epub 2024 Aug 22.
6
Evaluating outcomes of transjugular intrahepatic portosystemic shunt procedure among Native Americans.评估美国原住民经颈静脉肝内门体分流术的治疗效果。
Am J Med Sci. 2025 Feb;369(2):145-151. doi: 10.1016/j.amjms.2024.08.008. Epub 2024 Aug 21.
7
Presence of chronic complications differentiates in-hospital outcomes of transjugular intrahepatic portosystemic shunt in patients with diabetes mellitus.慢性并发症的存在可区分糖尿病患者经颈静脉肝内门体分流术的院内结局。
Am J Med Sci. 2025 Oct;370(4):358-364. doi: 10.1016/j.amjms.2025.07.011. Epub 2025 Jul 16.
8
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.肝硬化失代偿期食管静脉曲张出血患者的二级预防:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013122. doi: 10.1002/14651858.CD013122.pub2.
9
Preemptive Transjugular Intrahepatic Portosystemic Shunt in Variceal Bleeding: A Real-World Study in a Tertiary Hospital.预防性经颈静脉肝内门体分流术治疗静脉曲张出血:在一家三级医院的真实世界研究
GE Port J Gastroenterol. 2024 Oct 11;32(4):257-263. doi: 10.1159/000541307. eCollection 2025 Jul.
10
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review.经颈静脉肝内门体分流术对肝硬化患者营养状况的影响:系统评价。
Nutrients. 2023 Mar 27;15(7):1617. doi: 10.3390/nu15071617.

本文引用的文献

1
Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes.跨肝静脉门体分流术结局的种族差异。
BMJ Open Gastroenterol. 2022 Jan;9(1). doi: 10.1136/bmjgast-2021-000747.
2
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.经颈静脉肝内门体分流术(TIPS):当前适应证及改善治疗效果的策略
Intern Emerg Med. 2020 Jan;15(1):37-48. doi: 10.1007/s11739-019-02252-8. Epub 2020 Jan 9.
3
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index.利用医院管理数据识别再入院和住院死亡率增加的风险:AHRQ埃利克斯豪泽共病指数
Med Care. 2017 Jul;55(7):698-705. doi: 10.1097/MLR.0000000000000735.
4
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.83884例经颈静脉肝内门体分流术患者住院死亡率的全国趋势及预测因素
World J Gastroenterol. 2016 Jul 7;22(25):5780-9. doi: 10.3748/wjg.v22.i25.5780.
5
Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.未被充分研究的种族群体中慢性肝病和肝硬化的潜在病因患病率:多民族队列研究
Hepatology. 2016 Dec;64(6):1969-1977. doi: 10.1002/hep.28677. Epub 2016 Jul 17.
6
National Trends and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Creation Using the Nationwide Inpatient Sample.利用全国住院患者样本分析经颈静脉肝内门体分流术创建的全国趋势和结果
J Vasc Interv Radiol. 2016 Jun;27(6):838-45. doi: 10.1016/j.jvir.2015.12.013. Epub 2016 Mar 7.
7
Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control.亚裔美国人中的乙型肝炎:患病率、进展及控制前景。
World J Gastroenterol. 2015 Nov 14;21(42):11924-30. doi: 10.3748/wjg.v21.i42.11924.
8
The use of transjugular intrahepatic portosystemic stent shunt (TIPS) in the management of portal hypertensive bleeding.经颈静脉肝内门体分流术(TIPS)在门静脉高压性出血管理中的应用。
J Chin Med Assoc. 2014 Aug;77(8):395-402. doi: 10.1016/j.jcma.2014.05.010. Epub 2014 Jul 12.
9
Barriers to health care access in 13 Asian American communities.13个亚裔美国人社区获得医疗保健服务的障碍。
Am J Health Behav. 2010 Jan-Feb;34(1):21-30. doi: 10.5993/ajhb.34.1.3.
10
TIPS versus transcatheter sclerotherapy for gastric varices.经颈静脉肝内门体分流术与经导管硬化治疗术治疗胃静脉曲张的比较
AJR Am J Roentgenol. 2004 Aug;183(2):369-76. doi: 10.2214/ajr.183.2.1830369.

接受经颈静脉肝内门体分流术的亚裔美国人住院死亡率较高。

Higher In-Hospital Mortality among Asian Americans Undergoing Transjugular Intrahepatic Portosystemic Shunt Procedure.

作者信息

Li Renxi, Sarin Shawn

机构信息

The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Department of Interventional Radiology, The George Washington University Hospital, Washington, DC, USA.

出版信息

Visc Med. 2024 Aug;40(4):169-175. doi: 10.1159/000538356. Epub 2024 Apr 9.

DOI:10.1159/000538356
PMID:39157728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11326761/
Abstract

BACKGROUND

Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure to alleviate portal hypertension in patients with decompensated liver cirrhosis. While prior research highlighted racial disparities in TIPS, Asian Americans were not included in the investigation. This study aimed to investigate disparities in the immediate postprocedural outcomes among Asian American patients who underwent TIPS.

METHODS

The study identified Asian American and Caucasian patients who underwent TIPS in the National Inpatient Sample from Q4 2015-2020. Preprocedural factors, including demographics, comorbidities, primary payer status, and hospital characteristics, were matched by 1:2 propensity-score matching between the groups. In-hospital outcomes after TIPS were examined.

RESULTS

There were 6,658 patients who underwent TIPS with 128 (1.92%) Asian Americans and 4,574 (68.70%) Caucasians, where 218 Caucasians were matched to all Asian Americans. Asian Americans had higher in-hospital mortality (14.06% vs. 7.34%, = 0.04) and higher total hospital charge (253,756 ± 37,867 vs. 163,391 ± 10,265 US dollars, = 0.02). The occurrence of hepatic encephalopathy, acute kidney injury, transfers out to other hospital facilities, and length of stay did not differ between cohorts.

CONCLUSION

Despite their heightened risk for cirrhosis, Asian Americans are significantly underrepresented in TIPS and had higher in-hospital mortality after TIPS. This highlights the need for enhanced access to diagnosis and treatment care of liver cirrhosis for Asian Americans.

摘要

背景

经颈静脉肝内门体分流术(TIPS)是一种用于缓解失代偿期肝硬化患者门静脉高压的手术。虽然先前的研究强调了TIPS手术中的种族差异,但亚裔美国人并未纳入调查范围。本研究旨在调查接受TIPS手术的亚裔美国患者术后即刻结局的差异。

方法

该研究在2015年第四季度至2020年的全国住院患者样本中,确定了接受TIPS手术的亚裔美国人和白种人患者。术前因素,包括人口统计学、合并症、主要付款人状况和医院特征,通过两组之间1:2的倾向评分匹配进行匹配。对TIPS术后的住院结局进行了检查。

结果

共有6658例患者接受了TIPS手术,其中亚裔美国人128例(1.92%),白种人4574例(68.70%),218例白种人与所有亚裔美国人进行了匹配。亚裔美国人的住院死亡率更高(14.06%对7.34%,P = 0.04),总住院费用也更高(253756±37867美元对163391±10265美元,P = 0.02)。肝性脑病、急性肾损伤、转至其他医院设施的发生率以及住院时间在两组之间没有差异。

结论

尽管亚裔美国人患肝硬化的风险更高,但他们在TIPS手术中的占比明显过低,且TIPS术后的住院死亡率更高。这凸显了改善亚裔美国人肝硬化诊断和治疗可及性的必要性。